Main Navigation

Mercia
  • Ventures
  • Debt
  • Private equity
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us

Audience

|

Change

  • Ventures
  • Debt
  • Private equity
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub
  • Ventures
  • Debt
  • Private equity
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub

MEIF II Equity - East and South East Midlands

Eye therapy company raises £4.8m to boost overseas expansion

6th February, 2026

NuVision Biotherapies, a spin-out whose products speed up healing of eye conditions, has raised a further £4.8m...

NuVision's OmniLenz product

Latest news

Search all news
MEIF II Equity - East and South East Midlands | 6th February, 2026
Eye therapy company raises £4.8m to boost overseas expansion
Northern VCTs | 28th January, 2026
Insurtech marks another first with platform that spots gaps in cover
MEIF II Equity - East and South East Midlands | 22nd January, 2026
‘Space defence’ start-up raises £2m for satellite launch
MEIF II Equity - West Midlands | 19th January, 2026
Former radio presenter secures £1.8m for gut-friendly toothpaste
Northern VCTs | 17th December, 2025
Ben raises $27.5m to fix employee benefits for global enterprises
NPIF II Debt | 9th December, 2025
Rail telecoms specialist on track for growth after funding boost

Insights

Search all insights
All funds | 3rd December, 2025
Mercia’s FY26 interim results presentation
All funds | 2nd December, 2025
Mercia announces interim results for the six months ended 30 September 2025.
All funds | 2nd July, 2025
Mercia’s FY25 Preliminary Results presentation

Mercia TV

Search all videos
| 30th January, 2026
In conversation: Dr Mark Payton & Paul Bryant
| 20th January, 2026
Ben | All-in-one benefit management
| 2nd December, 2025
Optellum | Advancing early lung cancer detection with AI
Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept

© 2026 Mercia Asset Management

  • Contact us
  • Privacy policy
  • Terms and conditions
  • Modern Slavery Statement
  • Diversity, Equity & Inclusion Policy
  • Sustainability

Mercia Asset Management PLC is registered in England and Wales: 09223445. Its subsidiaries, Mercia Fund Management Limited, Mercia Regional Ventures Limited, Mercia Business Loans Limited and Frontier Development Capital Limited are authorised and regulated by the Financial Conduct Authority.

Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept